Brand Details
Sanofi
– Founded 2004
HQ: Paris, France
Website: https://www.sanofi.com
Segments: Pharmaceuticals, Diabetes Care
A global biopharmaceutical company focused on diabetes management.
About the Seller / Brand
| Company | Sanofi |
|---|---|
| Website | https://www.sanofi.com |
| HQ | Paris, France |
| Phone | +33 1 53 77 40 00 |
| Company LinkedIn | |
| Glassdoor | Glassdoor |
| Address | 54 Rue La Boétie, 75008 Paris, France |
| Verified | 90% confidence (data from AI) |
Company Journey
| 2004 | Sanofi-Synthélabo merges with Aventis to form Sanofi-Aventis. |
| 2011 | Sanofi rebrands as Sanofi after dropping Aventis from its name. |
| 2015 | Acquisition of the biotech company Bioverativ. |
| 2018 | Acquisition of the consumer healthcare business of Boehringer Ingelheim. |
| 2020 | Sanofi announces collaboration with GSK for COVID-19 vaccine development. |
| 2021 | Sanofi's COVID-19 vaccine enters clinical trials. |
Sanofi is a global healthcare company focused on human health, with a strong presence in pharmaceuticals and vaccines. It was formed through the merger of Sanofi-Synthélabo and Aventis, and has since expanded through various acquisitions and collaborations, particularly in the fields of biotechnology and vaccines.
Confidence: 90%
A global biopharmaceutical company focused on diabetes management.
HQ: Paris, France
Founded: 2004
Parent Brand:
Segments: Pharmaceuticals, Diabetes Care
